8-K - Cardiff Oncology, Inc. (0001213037) (Filer)
Published . Updated .
8-K - Cardiff Oncology filed an 8-K with the SEC on Oct 27 (a notice of a material company event).
Directly affected
- CRDF Cardiff Oncology-40.4% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Cardiff Oncology belongs to, so it often moves with news about it.
- AMGN Amgen+18.4% 30d
Amgen is a peer of Cardiff Oncology in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+8.4% 30d
Gilead Sciences is a peer of Cardiff Oncology in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna+38.3% 30d
Moderna is a peer of Cardiff Oncology in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-18.7% 30d
argenx SE is a peer of Cardiff Oncology in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Cardiff Oncology in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| CRDF | +6.86% | +1.60% | base | after close | after close | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| AMGNNo price data for this ticker | — | — | — | — | — | — | — |
| GILDNo price data for this ticker | — | — | — | — | — | — | — |
| MRNANo price data for this ticker | — | — | — | — | — | — | — |
| ARGXNo price data for this ticker | — | — | — | — | — | — | — |
| RVMDNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-27 AccNo: 0001493152-26-048720 Size: 249 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments t…
Source: sec-edgar
Cardiff Oncology (CRDF)
Across 18 earlier stories, Cardiff Oncology (CRDF) the next day averaged -6.43%. The largest gain was -3.35% and the largest drop was -15.35%, from 18 prices.
| Company | When | Average | Largest gain | Largest drop | Prices |
|---|---|---|---|---|---|
| Cardiff Oncology (CRDF) | the next day | -6.43% | -3.35% | -15.35% | 18 |
| Cardiff Oncology (CRDF) | three days later | -11.01% | -10.82% | -11.84% | 17 |
- 8-K - Cardiff Oncology, Inc. (0001213037) (Filer)
- Breast cancer survivor shares story of hope and healing
- Young cancer survivor shares hope through art
- Pope Leo diagnosed with lung cancer as growth removed during surgery
- Pope Leo diagnosed with lung cancer as growth removed in surgery
- Liver Cancer Survivor Shares Why Patients Should Speak Up About Their Care
Price since this story was published: Cardiff Oncology (CRDF)
| Company | When | Move | Status |
|---|---|---|---|
| Cardiff Oncology (CRDF) | three days earlier | +1.60% | final price |
| Cardiff Oncology (CRDF) | five days earlier | +6.86% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 35 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 62 days before publication. Filed 5 Sep 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $1,001 - $15,000 on 12 Aug 2026. That is 76 days before publication. Filed 2 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 78 days before publication. Filed 4 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 33 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 60 days before publication. Filed 8 Oct 2026. View the filing.
- Scott A Kupor, an executive branch official, sold Revolution Medicines (RVMD), worth $1,001 - $15,000 on 30 Jul 2026. That is 89 days before publication. Filed 30 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Cardiff Oncology (CRDF)
Companies carried with this story
- CRDF Cardiff Oncology
In “8-K - Cardiff Oncology, Inc. (0001213037) (Filer),” Cardiff Oncology (CRDF) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> CRDF
How “8-K - Cardiff Oncology, Inc. (0001213037) (Filer)” reaches Cardiff Oncology (CRDF)
On 27 Oct 2026, “8-K - Cardiff Oncology, Inc. (0001213037) (Filer)” is the story that connects Cardiff Oncology (CRDF) to this story.
For Cardiff Oncology (CRDF), the reason on file says SEC 8-K filing -> direct issuer disclosure -> CRDF
The price range for Cardiff Oncology (CRDF), and the dates in the story
CRDF traded between 0.79 and 1.24 across 20 sessions. The latest close on file is 0.80.
How strong the case is around Cardiff Oncology (CRDF)
14 out of 100
“8-K - Cardiff Oncology, Inc. (0001213037) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.